Facebook Twitter Linkedin
#BeyondASCO
Register to Attend

CME Information

Beyond the Congress:  Key Conversations in Hematologic Malignancies from the 2022 ASCO and EHA Annual Meetings
August 5, 2022

Jointly provided by Postgraduate Institute for Medicine and Bio Ascend  LLC.

This activity is supported by independent educational grants from Bristol Myers Squibb and Seagen Inc.

Target Audience

This activity is intended for oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists engaged in the care of patients with hematologic malignancies.

Educational Objectives

After completing this activity, the participant should be better able to:
  • Assess efficacy and safety data of novel therapeutic approaches for indolent and aggressive lymphomas
  • Review clinical trial results of novel approaches to treat patients with multiple myeloma, including antibody-drug conjugates, bispecific antibodies, CAR T-cell therapy, and others
  • Evaluate patient- and disease-related factors that can influence the selection and sequencing of therapies for patients with CLL
  • Determine the optimal biomarker-driven therapeutic approaches that tailor therapy for patients with acute leukemia, including those that harbor actionable mutations
  • Evaluate the most recent results from clinical trials investigating emerging treatment options and novel formulations in myeloproliferative neoplasms

Faculty

CLICK HERE

Program Agenda

CLICK HERE

Joint Accreditation Statement

Jointly Accredited Provider

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Bio Ascend LLC.   Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Planners and Managers

The PIM planners and managers have nothing to disclose. The Bio Ascend LLC planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to obtain your CME/CE certificate, please follow the steps below at the conclusion of the activity:

 

  • 1) Go to www.cmeuniversity.com
  • 2) Login or Create a New Account (will take less than 1 minute)
    • If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    • After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  • 3) Type in 16632 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  • 4) Click on the activity title when it appears
  • 5) Choose the type of credit you desire
  • 6) Complete the online assessment
  • 7) Receive an immediate CME/CE Certificate to download and/or print for your files

If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.